Central venous catheters are thin, hollow, flexible tubes that are inserted in large central veins (jugular, subclavian and femoral veins) to administer medications, fluids, blood products or to obtain central venous pressure measurements. Central venous catheters have a variety of uses in emergency departments, operating rooms, and ICUs for both short-term and long-term treatment.

The global Central Venous Catheter Market is estimated to be valued at US$ 2388.55 Mn  in 2023 and is expected to exhibit a CAGR of 11%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics
Growing geriatric population is expected to be a key driver for the growth of the central venous catheter market. According to the UN report, by 2050 about 16% of the world’s population will be over age 65, up from 9% in 2019. With ageing comes complex health needs, including higher risk of chronic illnesses such as cancer requiring long term venous access devices. In addition, rise in number of surgeries is also fueling the demand for central venous catheters. According to the American Society of Plastic Surgeons estimates, there were more than 26 million inpatient surgeries performed in the United States in 2020. With increase in surgical procedures, usage of central venous catheters also rise as they are an important component of perioperative care to deliver medications or fluids. Thus, growing geriatric population and increasing surgical volume are some of the key factors propelling the growth of central venous catheter market over the forecast period.

SWOT Analysis
Strength: Central venous catheters have a broad range of clinical applications and can be used for both short term and long term infusion therapies. They provide immediate vascular access for fluid therapy, medication administration, blood sampling, and hemodynamic monitoring procedures. Central venous catheters can remain in place for weeks or months at a time to facilitate outpatient treatment or prolonged antibiotic therapy which reduces the need for multiple peripheral IV insertions. They offer a reliable means of venous access even in patients with poor peripheral veins.

Weakness: Central venous catheters have risks of complications like infection, thrombosis, pneumothorax and inadvertent arterial puncture or hemorrhage during insertion. They also require appropriate insertion technique and ongoing care to reduce risks. Improper placement, maintenance or removal of central lines can lead to serious injuries.

Opportunity: Advancements in catheter design, coatings and closed systems are expected to drive the adoption of central venous catheters. Miniaturization of catheters allows use in smaller vessels and children. Antimicrobial impregnated catheters have reduced rates of catheter related bloodstream infections. Adoption in home healthcare setting will provide opportunities.

Threats: Alternatives like midline catheters and peripherally inserted central catheters pose competition. Strict regulations pertaining to product approval and recalls limit market growth. Reimbursement policies also impact the demand.


Key Takeaways

The global Central Venous Catheter Market Share is expected to witness high growth over the forecast period of 2023 to 2030 supported by aging population, rising incidence of chronic diseases requiring long term vascular access, advancements in catheter technology and increasing ambulatory care.

Regional analysis: North America currently dominates the central venous catheter market owing to large patient pool, favorable reimbursements, technological advancements and presence of major players in the region. Asia Pacific is poised to grow at the fastest pace due to improving healthcare infrastructure, growing medical tourism, rising healthcare spending and expanding patient base.

Key players operating in the central venous catheter market are BASF SE, Braskem S.A., Compagnie de Saint-Gobain S.A. (CertainTeed Corporation), Corbion Purac, FKuR Kunststoff GmbH.

Check below related articles on this topic: https://www.newsanalyticspro.com/central-venous-catheters-market-propelled-by-rising-geriatric-population/

https://www.newsintv.com/health/crispr-and-cas-gene-a-revolutionary-gene-editing-technology/